Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer

NCT04358341 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Irinotecan
DRUG: DOXOrubicin Liposome Injection
DRUG: 5fluorouracil

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University